Align Technology Unveils Scientific Breakthrough in Class II Malocclusion Treatment with Innovative Invisalign System

Reuters
15 Jul
Align Technology Unveils Scientific Breakthrough in Class II Malocclusion Treatment with Innovative Invisalign System

Align Technology Inc. has introduced a groundbreaking advancement in orthodontic treatment with the commercial availability of the Invisalign® System featuring mandibular advancement and occlusal blocks, specifically designed for Class II skeletal and dental correction in kids and teenagers. This innovation allows for simultaneous mandible advancement and teeth alignment, enhancing treatment predictability and efficiency. The results, already presented, demonstrate significant investment in digital orthodontic solutions, empowering doctors to achieve better outcomes and improve patient experiences. This new system expands Align's Class II treatment portfolio, providing a comprehensive solution for treating malocclusions caused by mandibular retrusion.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Align Technology Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20250714266863) on July 15, 2025, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10